Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study
Journal of Medical Internet Research · 25.04.2023 · 25 · e38680
DOI: 10.2196/38680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 25.04.2023. Verfasst von Benli Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is a worldwide public health concern. Mobile health management platforms could be a potential way to achieve effective glycemic control.
Objective
This study aimed to evaluate the real-world effectiveness of the Lilly Connected Care Program (LCCP) platform in glycemic control among patients with T2DM in China.
Methods
This retrospective study included Chinese patients with T2DM (aged ≥18 years) from April 1, 2017, to January 31, 2020, for the LCCP group and from January 1, 2015, to January 31, 2020, for the non-LCCP group. Propensity score matching was used to match the LCCP and non-LCCP groups to reduce confounding, with covariates including age, sex, the duration of diabetes, baseline hemoglobin A1c (HbA1c), and the number of oral antidiabetic medication classes. HbA1c reduction over 4 months, the proportions of patients achieving an HbA1c reduction of ≥0.5% or ≥1%, and the proportions of patients reaching to target HbA1c level of ≤6.5% or
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China.
- Department of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin, China.
- Department of Endocrinology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
- Lilly Suzhou Pharmaceutical Co Ltd, Shanghai, China.
- Department of Endocrinology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Benli Su, Yu Chen, Xingping Shen, Jianchao Guo, Yuchen Ding, Xiao Ma, Yuxin Yang, Dongfang Liu
Zitieren
APA
Su, B., Chen, Y., Shen, X., Guo, J., Ding, Y., Ma, X., Yang, Y., & Liu, D. (2023). Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study. Journal of Medical Internet Research, 25, e38680. https://doi.org/10.2196/38680
Vancouver
Su B, Chen Y, Shen X, Guo J, Ding Y, Ma X, et al. Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study. Journal of Medical Internet Research. 2023;25:e38680. doi:10.2196/38680
BibTeX
@article{Su2023,
author = {Su, Benli and Chen, Yu and Shen, Xingping and Guo, Jianchao and Ding, Yuchen and Ma, Xiao and Yang, Yuxin and Liu, Dongfang},
title = {Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study},
journal = {Journal of Medical Internet Research},
year = {2023},
volume = {25},
pages = {e38680},
doi = {10.2196/38680}
}
EUVIMED